|
|
 | | | |
- close
- close
- close
- close
| |||||||||
CVS » Topics » Risks related to the frequency and rate of the introduction of new prescription drugs as well as generic alternatives to brand name prescription products.This excerpt taken from the CVS 10-K filed Feb 27, 2009. Risks related to the frequency and rate of the introduction of new prescription drugs as well as generic alternatives to brand name prescription products. The profitability of retail and mail order pharmacy businesses are dependent upon the utilization of prescription drug products. Utilization trends are affected by the introduction of new and successful prescription pharmaceuticals as well as lower priced generic alternatives to existing brand name products. Accordingly, a slowdown in the introduction of new and successful prescription pharmaceuticals and/or generic alternatives (the sale of which normally yield higher gross profit margins than brand name equivalents) could adversely affect our business, financial position and results of operations. This excerpt taken from the CVS 10-K filed Feb 27, 2008. Risks related to the frequency and rate of the introduction of new prescription drugs as well as generic alternatives to brand name prescription products. The profitability of retail and mail order pharmacy businesses are dependent upon the utilization of prescription drug products. Utilization trends are affected by the introduction of new and successful prescription pharmaceuticals as well as lower priced generic alternatives to existing brand name products. Accordingly, a slowdown in the introduction of new and successful prescription pharmaceuticals and/or generic alternatives (the sale of which normally yield higher gross profit margins than brand name equivalents) could adversely affect our business, financial position and results of operations. | EXCERPTS ON THIS PAGE:
|
| |||||||
